Last reviewed · How we verify
NCT06583005
Vibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic Medication
NA trial testing Vibrotactile Coordinated Reset in Parkinson Disease, Idiopathic in 20 participants. Not yet recruiting.
15 May 2027
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 15 February 2025 |
| Primary completion | 15 May 2027 |
| Estimated completion | 15 May 2027 |
Drugs / interventions tested
- Vibrotactile Coordinated Reset
Conditions studied
- Parkinson Disease, Idiopathic — all drugs for Parkinson Disease, Idiopathic →
Sponsor
Stanford University
Who can join
18 and older, female only, with Parkinson Disease, Idiopathic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical trial is to test the efficacy of vibrotactile coordinated reset stimulation to improve movement ability and other symptoms of human subject participants with Parkinsons Disease who take dopaminergic medication and are unable to withhold this medication. Participants will be followed for five years and make a total of five study visits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06583005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vibrotactile Coordinated Reset
Trials testing the same drug.
- NCT06290609 — Vibrotactile Coordinated Reset for Spasticity After Spinal Cord Injury · NA · not yet recruiting
Other recruiting trials for Parkinson Disease, Idiopathic
Currently open trials in the same condition.
- NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease · NA · recruiting
- NCT06609681 — Parkinson Disease: A Model of National Digital Interventions to Prevent or Slow a Rise of Non-Communicable · active not recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06583005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 3 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06583005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing